TY - JOUR AU - Petti, C. A. AU - Fowler, V. G. PY - 2003 DA - 2003// TI - Staphylococcus aureusbacteremia and endocarditis JO - Cardiol Clin VL - 21 UR - https://doi.org/10.1016/S0733-8651(03)00030-4 DO - 10.1016/S0733-8651(03)00030-4 ID - Petti2003 ER - TY - JOUR AU - Sista, R. R. AU - Oda, G. AU - Barr, J. PY - 2004 DA - 2004// TI - Methicillin-resistant Staphylococcus aureusinfections in ICU patients JO - Anesthesiol Clin North America VL - 22 UR - https://doi.org/10.1016/j.atc.2004.04.006 DO - 10.1016/j.atc.2004.04.006 ID - Sista2004 ER - TY - JOUR AU - Palavecino, E. PY - 2004 DA - 2004// TI - Community-acquired methicillin-resistant Staphylococcus aureusinfections JO - Clin Lab Med VL - 24 UR - https://doi.org/10.1016/j.cll.2004.03.007 DO - 10.1016/j.cll.2004.03.007 ID - Palavecino2004 ER - TY - JOUR AU - Fluit, A. C. AU - Wielders, C. L. AU - Verhoef, J. AU - Schmithz, F. J. PY - 2001 DA - 2001// TI - Epidemiology and susceptibility of 3,051 Staphylococcus aureusisolates from 25 university hospitals participating in the European SENTRY study JO - J Clin Microbiol VL - 39 UR - https://doi.org/10.1128/JCM.39.10.3727-3732.2001 DO - 10.1128/JCM.39.10.3727-3732.2001 ID - Fluit2001 ER - TY - JOUR AU - Jevons, M. P. PY - 1961 DA - 1961// TI - "Celbenin" – resistant staphylococci JO - BMJ VL - 1 UR - https://doi.org/10.1136/bmj.1.5219.124-a DO - 10.1136/bmj.1.5219.124-a ID - Jevons1961 ER - TY - JOUR AU - Eguia, J. M. AU - Chambers, H. F. PY - 2003 DA - 2003// TI - Community-acquired methicillin resistant Staphylococcus aureus: epidemiology and potential virulence factors JO - Curr Infect Dis Rep VL - 5 UR - https://doi.org/10.1007/s11908-003-0087-6 DO - 10.1007/s11908-003-0087-6 ID - Eguia2003 ER - TY - JOUR AU - Fridkin, S. K. AU - Hageman, J. C. AU - Morrison, M. AU - Sanza, L. T. AU - Como-Sabetti, K. AU - Jernigan, J. A. AU - Harriman, K. AU - Harrison, L. H. AU - Lynfield, R. AU - Farley, M. M. PY - 2005 DA - 2005// TI - Methicillin-resistant Staphylococcus aureusdisease in three communities JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa043252 DO - 10.1056/NEJMoa043252 ID - Fridkin2005 ER - TY - JOUR AU - Spellberg, B. AU - Powers, J. H. AU - Brass, E. P. AU - Miller, L. G. AU - Edwards, J. E. PY - 2004 DA - 2004// TI - Trends in antimicrobial drug development: implications for the future JO - Clin Infect Dis VL - 38 UR - https://doi.org/10.1086/420937 DO - 10.1086/420937 ID - Spellberg2004 ER - TY - JOUR AU - Chopra, I. PY - 2003 DA - 2003// TI - Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures JO - Expert Rev Anti Infect Ther VL - 1 UR - https://doi.org/10.1586/14787210.1.1.45 DO - 10.1586/14787210.1.1.45 ID - Chopra2003 ER - TY - JOUR AU - Stefani, S. AU - Varaldo, P. E. PY - 2003 DA - 2003// TI - Epidemiology of methicillin-resistant staphylococci in Europe JO - Clin Microbiol Infect VL - 9 UR - https://doi.org/10.1111/j.1469-0691.2003.00698.x DO - 10.1111/j.1469-0691.2003.00698.x ID - Stefani2003 ER - TY - JOUR AU - Eliopoulos, G. M. PY - 1989 DA - 1989// TI - Synergism and antagonism JO - Infect Dis Clin North Am VL - 3 ID - Eliopoulos1989 ER - TY - JOUR AU - Alvarez-Lerma, F. PY - 1996 DA - 1996// TI - Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit JO - Intensive Care Med VL - 22 UR - https://doi.org/10.1007/BF01712153 DO - 10.1007/BF01712153 ID - Alvarez-Lerma1996 ER - TY - JOUR PY - 2005 DA - 2005// TI - Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia JO - Am J Respir Crit Care Med VL - 171 UR - https://doi.org/10.1164/rccm.200405-644ST DO - 10.1164/rccm.200405-644ST ID - ref13 ER - TY - BOOK PY - 2003 DA - 2003// TI - Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically – Seventh Edition: Approved Standard M7-A6 PB - NCCLS CY - Villanova, PA, USA ID - ref14 ER - TY - CHAP PY - 2003 DA - 2003// TI - Performance Standards for Antimicrobial Susceptibility Testing BT - Thirteenth Informational Supplement M 100-S 13 PB - NCCLS CY - Villanova, PA, USA ID - ref15 ER - TY - CHAP AU - Eliopoulos, G. M. AU - Moellering, R. C. ED - Lorian, V. PY - 1991 DA - 1991// TI - Antimicrobial combinations BT - Antibiotics in laboratory medicine PB - Baltimore CY - Wilkins Co ID - Eliopoulos1991 ER - TY - JOUR AU - Pankey, G. A. AU - Ashcraft, D. S. PY - 2005 DA - 2005// TI - In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.7.2959-2964.2005 DO - 10.1128/AAC.49.7.2959-2964.2005 ID - Pankey2005 ER - TY - JOUR AU - Odds, F. C. PY - 2003 DA - 2003// TI - Synergy, antagonism, and what the chequerboard puts between them JO - J Antimicrob Chemother VL - 52 UR - https://doi.org/10.1093/jac/dkg301 DO - 10.1093/jac/dkg301 ID - Odds2003 ER - TY - JOUR AU - Michéa Hamzehpour, M. AU - Kahr, A. AU - Pechère, J. C. PY - 1994 DA - 1994// TI - In vitro stepwise selection of resistance to quinolones, β-lactams and amikacin in nosocomial Gram-negative bacilli JO - Infection VL - 22 UR - https://doi.org/10.1007/BF01793574 DO - 10.1007/BF01793574 ID - Michéa Hamzehpour1994 ER - TY - JOUR AU - Kollef, M. H. PY - 2003 DA - 2003// TI - The importance of appropriate initial antibiotic therapy for hospital-acquired infections JO - Am J Med VL - 115 UR - https://doi.org/10.1016/j.amjmed.2003.09.002 DO - 10.1016/j.amjmed.2003.09.002 ID - Kollef2003 ER - TY - JOUR AU - Huang, V. AU - Rybak, M. J. PY - 2005 DA - 2005// TI - Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureusin an in vitro pharmacodynamic infection model JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.1.302-308.2005 DO - 10.1128/AAC.49.1.302-308.2005 ID - Huang2005 ER - TY - JOUR AU - Jacqueline, C. AU - Navas, D. AU - Batard, E. AU - Miegeville, A. F. AU - Le Mabecque, V. AU - Kergueris, M. F. AU - Bugnon, D. AU - Potel, G. AU - Caillon, J. PY - 2005 DA - 2005// TI - In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.1.45-51.2005 DO - 10.1128/AAC.49.1.45-51.2005 ID - Jacqueline2005 ER - TY - JOUR AU - Grohs, P. AU - Kitzis, M. D. AU - Gutmann, L. PY - 2003 DA - 2003// TI - In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus. JO - Antimicrob Agents Chemother VL - 47 UR - https://doi.org/10.1128/AAC.47.1.418-420.2003 DO - 10.1128/AAC.47.1.418-420.2003 ID - Grohs2003 ER - TY - JOUR AU - Rand, K. H. AU - Houck, H. J. PY - 2004 DA - 2004// TI - Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus JO - Antimicrob Agents Chemother VL - 48 UR - https://doi.org/10.1128/AAC.48.8.2871-2875.2004 DO - 10.1128/AAC.48.8.2871-2875.2004 ID - Rand2004 ER - TY - JOUR AU - Lozniewski, A. AU - Lion, C. AU - Mory, F. AU - Weber, M. PY - 2001 DA - 2001// TI - In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis JO - J Antimicrob Chemother VL - 47 UR - https://doi.org/10.1093/jac/47.1.83 DO - 10.1093/jac/47.1.83 ID - Lozniewski2001 ER - TY - JOUR AU - Rochon-Edouard, S. AU - Pestel-Caron, M. AU - Lemeland, J. F. AU - Caron, F. PY - 2000 DA - 2000// TI - In vitro synergistic effects of double and triple combinations of β-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureusstrains JO - Antimicrob Agents Chemother VL - 44 UR - https://doi.org/10.1128/AAC.44.11.3055-3060.2000 DO - 10.1128/AAC.44.11.3055-3060.2000 ID - Rochon-Edouard2000 ER - TY - JOUR AU - Thamlikitkul, V. PY - 1991 DA - 1991// TI - Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureusand coagulase-negative staphylococci by time-kill method JO - J Med Assoc Thai VL - 74 ID - Thamlikitkul1991 ER - TY - JOUR AU - Barr, J. G. AU - Smyth, E. T. AU - Hogg, G. M. PY - 1990 DA - 1990// TI - In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis JO - Eur J Clin Microbiol Infect Dis VL - 9 UR - https://doi.org/10.1007/BF01967378 DO - 10.1007/BF01967378 ID - Barr1990 ER - TY - JOUR AU - Ackermann, B. H. AU - Vannier, A. M. AU - Eudy, E. B. PY - 1992 DA - 1992// TI - Analysis of vancomycin time kill studies with Staphylococcusspecies by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response JO - Antimicrob Agents Chemother VL - 36 UR - https://doi.org/10.1128/AAC.36.8.1766 DO - 10.1128/AAC.36.8.1766 ID - Ackermann1992 ER - TY - JOUR AU - Watanakunalorn, C. PY - 1990 DA - 1990// TI - In-vitro selection of resistance of Staphylococcus aureusto teicoplanin and vancomycin JO - J Antimicrob Chemother VL - 25 UR - https://doi.org/10.1093/jac/25.1.69 DO - 10.1093/jac/25.1.69 ID - Watanakunalorn1990 ER - TY - JOUR AU - Biavasco, F. AU - Giovanetti, E. AU - Montanari, M. P. AU - Lupidi, R. AU - Varaldo, P. E. PY - 1991 DA - 1991// TI - Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species JO - J Antimicrob Chemother VL - 27 UR - https://doi.org/10.1093/jac/27.1.71 DO - 10.1093/jac/27.1.71 ID - Biavasco1991 ER - TY - JOUR AU - Pfeltz, R. F. AU - Singh, V. K. AU - Schmidt, J. L. AU - Batten, M. A. AU - Baranyk, C. S. AU - Nadakavukaren, M. J. AU - Jayaswal, R. K. AU - Wilkinson, B. J. PY - 2000 DA - 2000// TI - Characterization of passage-selected vancomycin-resistant Staphylococcus aureusstrains of diverse parental backgrounds JO - Antimicrob Agents Chemother VL - 44 UR - https://doi.org/10.1128/AAC.44.2.294-303.2000 DO - 10.1128/AAC.44.2.294-303.2000 ID - Pfeltz2000 ER - TY - JOUR AU - Schaaff, F. AU - Reipert, A. AU - Bierbaum, G. PY - 2002 DA - 2002// TI - An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.11.3540-3548.2002 DO - 10.1128/AAC.46.11.3540-3548.2002 ID - Schaaff2002 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/7/111/prepub UR - http://www.biomedcentral.com/1471-2334/7/111/prepub ID - ref34 ER -